This article about antithrombotic therapy in children is part of the 7th American College of
Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …

Venous thrombo‐embolism (VTE) is increasingly recognized in paediatric practice. Few
clinical trials have been performed in this area in children and management is largely …

Background Neonates and children differ from adults in physiology, pharmacologic
responses to drugs, epidemiology, and long-term consequences of thrombosis. This …

Methods A writing group was established with representation from the Council on Peripheral
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …

Methods: These guidelines are a joint effort of the European Crohn's and Colitis
Organization (ECCO) and the European Society of Paediatric Gastroenterology, Hepatology …

Thrombosis has long been recognized as a potentially lifethreatening complication in
children with congenital heart disease (CHD), children with acquired heart disease, and in …

This chapter about antithrombotic therapy in neonates and children is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Objective Clinical trials are lacking in pediatric cerebral sinovenous thrombosis (CSVT).
Neonates and children increasingly receive anticoagulant therapy (ACT) based on adult …

Abbreviations: ALL acute lymphoblastic leukemia; APTT qjactivated partial thromboplastin
time; AT antithrombin; BT Blalock-Taussig; CI confidence interval; CVL central venous line; …

Childhood stoke is increasingly recognized, but studies remain largely descriptive. Important
differences from adult stroke include the following:(1) frequently delayed or missed …